Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer

Mubarak Al-mansour¹, Ahmad Saadeddin², Sultan Alkhateeb³, Ashraf Abusamra⁴, Danny Rabah⁵, Mohammed Alotaibi⁶, Esam Murshid⁷, Abdullah Alsharm⁸, Imran Ahmad⁹, Khalid Alghamdi¹⁰, Shouki Bazarbashi^11
1 Princess Noura Oncology Center, Department of Surgery, King Khaled Hospital, King Abdulaziz Medical City-Jeddah, Saudi Arabia
² Department of Oncology, Division of Urology, King Abdulaziz Medical City, Riyadh, Saudi Arabia
³ Department of Surgery, Division of Urology, King Abdulaziz Medical City, Riyadh, Saudi Arabia
⁴ Section of Urology, Department of Surgery, King Khaled Hospital, King Abdulaziz Medical City-Jeddah, Saudi Arabia
⁵ Department of Surgery, Division of Urology, King Khalid University Hospital, College of Medicine; Princess Al-Johora Al-Ibrahim Centre for Cancer Research (Uro-Oncology Research Chair), King Saud University, Riyadh, Saudi Arabia
⁶ Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁷ Department of Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
⁸ Department of Oncology, King Fahad Medical City, Riyadh, Saudi Arabia
⁹ Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
¹⁰ Division of Urology, Security Forces Hospital, Riyadh, Saudi Arabia
¹¹ Section of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Correspondence Address:
Danny Rabah
Department of Surgery, Division of Urology, King Khalid University Hospital, College of Medicine, Princess Al-Johora Al-Ibrahim Centre for Cancer Research (Uro-Oncology Research Chair), King Saud University, Riyadh
Saudi Arabia

Check

DOI: 10.4103/0974-7796.140941

PMID: 25371600